FDA official announcements or SpectraWAVE press releases

SpectraWAVE Secures $50M Series B Led by Johnson & Johnson for HyperVue™ Expansion

Sep 11, 2024, 01:02 PM

SpectraWAVE has announced a $50 million Series B financing round aimed at driving commercial expansion and product additions to its HyperVue™ Imaging System. The funding round is led by Johnson & Johnson, with participation from Lumira Ventures, Deerfield Management, SV Health Investors, and S3 Ventures. CEO Eman Namati stated that this financing is expected to significantly enhance SpectraWAVE's capabilities in improving treatment and outcomes for patients with coronary artery disease.